viernes, 3 de abril de 2020

FAQs on Diagnostic Testing for SARS-CoV-2 | FDA

FAQs on Diagnostic Testing for SARS-CoV-2 | FDA



April 2 Update: New Information on Diagnostic Testing for SARS-CoV-2

Thank you for your interest in development of diagnostics for SARS-CoV-2.  The FDA has updated the answer to the following frequently asked question: 

  • I am having trouble obtaining viral transport media/universal transport media (VTM/UTM) and a flocked nasopharyngeal swab to collect and transport patient samples. Are there alternatives that I can use?
  • What happens if I do not have the instruments referenced in the authorization of the CDC’s EUA-authorized test?

No hay comentarios: